PL3544615T3 - Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego - Google Patents
Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowegoInfo
- Publication number
- PL3544615T3 PL3544615T3 PL17812273.5T PL17812273T PL3544615T3 PL 3544615 T3 PL3544615 T3 PL 3544615T3 PL 17812273 T PL17812273 T PL 17812273T PL 3544615 T3 PL3544615 T3 PL 3544615T3
- Authority
- PL
- Poland
- Prior art keywords
- escin
- beta
- oral compositions
- reducing acetaldehyde
- chokeberry juice
- Prior art date
Links
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 title 2
- AXNVHPCVMSNXNP-IVKVKCDBSA-N (2s,3s,4s,5r,6r)-6-[[(3s,4s,4ar,6ar,6bs,8r,8ar,9r,10r,12as,14ar,14br)-9-acetyloxy-8-hydroxy-4,8a-bis(hydroxymethyl)-4,6a,6b,11,11,14b-hexamethyl-10-[(e)-2-methylbut-2-enoyl]oxy-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-4-hydroxy-3, Chemical compound O([C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@]1(CO)C)C)(C)C[C@@H](O)[C@@]1(CO)[C@@H](OC(C)=O)[C@@H](C(C[C@H]14)(C)C)OC(=O)C(/C)=C/C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O AXNVHPCVMSNXNP-IVKVKCDBSA-N 0.000 title 1
- AXNVHPCVMSNXNP-GKTCLTPXSA-N Aescin Natural products O=C(O[C@H]1[C@@H](OC(=O)C)[C@]2(CO)[C@@H](O)C[C@@]3(C)[C@@]4(C)[C@@H]([C@]5(C)[C@H]([C@](CO)(C)[C@@H](O[C@@H]6[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O7)[C@@H](O)[C@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O7)[C@@H](C(=O)O)O6)CC5)CC4)CC=C3[C@@H]2CC1(C)C)/C(=C/C)/C AXNVHPCVMSNXNP-GKTCLTPXSA-N 0.000 title 1
- 241001444063 Aronia Species 0.000 title 1
- 229940093314 beta-escin Drugs 0.000 title 1
- AXNVHPCVMSNXNP-BEJCRFBNSA-N beta-escin Natural products CC=C(/C)C(=O)O[C@H]1[C@H](OC(=O)C)[C@]2(CO)[C@H](O)C[C@@]3(C)C(=CC[C@@H]4[C@@]5(C)CC[C@H](O[C@H]6O[C@@H]([C@H](O[C@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@@H]6O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)[C@@H]5CC[C@@]34C)[C@@H]2CC1(C)C AXNVHPCVMSNXNP-BEJCRFBNSA-N 0.000 title 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000001988 toxicity Effects 0.000 title 1
- 231100000419 toxicity Toxicity 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Addiction (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Obesity (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1619846.7A GB201619846D0 (en) | 2016-11-24 | 2016-11-24 | Saponin composition |
| PCT/IB2017/057395 WO2018096502A1 (en) | 2016-11-24 | 2017-11-24 | Oral compositions comprising beta-escin for reducing acetaldehyde toxicity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3544615T3 true PL3544615T3 (pl) | 2022-09-19 |
Family
ID=58073282
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL430029A PL430029A1 (pl) | 2016-11-24 | 2017-11-24 | Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu |
| PL17812273.5T PL3544615T3 (pl) | 2016-11-24 | 2017-11-24 | Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL430029A PL430029A1 (pl) | 2016-11-24 | 2017-11-24 | Kompozycja doustna zawierająca beta-escynę do obniżania toksyczności acetaldehydu |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10799550B2 (pl) |
| EP (1) | EP3544615B1 (pl) |
| JP (1) | JP7070933B2 (pl) |
| KR (1) | KR102569055B1 (pl) |
| AU (1) | AU2017365116B2 (pl) |
| CA (1) | CA3044504A1 (pl) |
| GB (1) | GB201619846D0 (pl) |
| PL (2) | PL430029A1 (pl) |
| WO (1) | WO2018096502A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020070732A1 (en) * | 2018-10-05 | 2020-04-09 | Escilab Sp Z O. O. | Oral composition comprising β-escin and the use thereof |
| CN116159145B (zh) * | 2023-01-31 | 2025-04-22 | 四川大学 | 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3533231B2 (ja) * | 1993-08-20 | 2004-05-31 | 森下仁丹株式会社 | アルコール吸収抑制剤 |
| JP4777495B2 (ja) * | 1999-04-01 | 2011-09-21 | 森下仁丹株式会社 | アルコール障害予防剤およびそれを含有する食品 |
| US20080299250A1 (en) * | 2005-12-30 | 2008-12-04 | Cadbury Holdings Limited | Chewing Gum Composition Containing Chokeberry |
| KR101383276B1 (ko) * | 2012-03-05 | 2014-04-08 | 염장열 | 아로니아 음료 농축액 및 그 제조방법 |
| KR20140090453A (ko) * | 2013-01-09 | 2014-07-17 | (주) 제이비케이자연의학연구소 | 아로니아 추출물을 함유하는 숙취예방, 숙취해소 또는 간 보호용 조성물 |
| PL405318A1 (pl) * | 2013-09-11 | 2015-03-16 | Cezary Bilski | Preparat złożony wspomagający odchudzanie na bazie wyciągów roślinnych |
| KR20160100572A (ko) * | 2015-02-16 | 2016-08-24 | 학교법인연세대학교 | 고미가 제거된 남가새 음료 및 이의 제조방법 |
| EP3078381A1 (en) * | 2015-04-10 | 2016-10-12 | Warszawski Uniwersytet Medyczny | Horse chestnut extract or escins for the treatment of alzheimer's disease |
-
2016
- 2016-11-24 GB GBGB1619846.7A patent/GB201619846D0/en not_active Ceased
-
2017
- 2017-11-24 PL PL430029A patent/PL430029A1/pl unknown
- 2017-11-24 KR KR1020197014741A patent/KR102569055B1/ko active Active
- 2017-11-24 AU AU2017365116A patent/AU2017365116B2/en active Active
- 2017-11-24 US US16/461,967 patent/US10799550B2/en active Active
- 2017-11-24 EP EP17812273.5A patent/EP3544615B1/en active Active
- 2017-11-24 WO PCT/IB2017/057395 patent/WO2018096502A1/en not_active Ceased
- 2017-11-24 JP JP2019528118A patent/JP7070933B2/ja active Active
- 2017-11-24 PL PL17812273.5T patent/PL3544615T3/pl unknown
- 2017-11-24 CA CA3044504A patent/CA3044504A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3044504A1 (en) | 2018-05-31 |
| JP2019535779A (ja) | 2019-12-12 |
| US20190321432A1 (en) | 2019-10-24 |
| EP3544615B1 (en) | 2022-05-18 |
| US10799550B2 (en) | 2020-10-13 |
| WO2018096502A1 (en) | 2018-05-31 |
| AU2017365116A1 (en) | 2019-05-23 |
| GB201619846D0 (en) | 2017-01-11 |
| EP3544615A1 (en) | 2019-10-02 |
| AU2017365116B2 (en) | 2023-06-22 |
| KR20190087437A (ko) | 2019-07-24 |
| JP7070933B2 (ja) | 2022-05-18 |
| KR102569055B1 (ko) | 2023-08-21 |
| PL430029A1 (pl) | 2021-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL278891A (en) | Anti-HER2 drug-antibody conjugates, preparations containing them and their uses | |
| IL258082B (en) | History of benzaimidazole and pharmaceutical preparations containing them | |
| ZA201801511B (en) | Flavonoid compositions and methods of use | |
| PL3628691T3 (pl) | Amfifilowe pochodne polisacharydów i zawierające je kompozycje | |
| SI3426348T1 (sl) | Derivat 3-dezoksi in njegovi farmacevtski sestavki | |
| IL247836A0 (en) | 1, 3-benzodioxole derivatives, preparations containing them and their uses | |
| IL271275B1 (en) | Preparations containing croons and their uses | |
| ZA201801692B (en) | 17-hydroxyprogesterone ester-containing oral compositions and related methods | |
| EP3223609A4 (en) | Novel diterpene glycosides, compositions and purification methods | |
| IL271759A (en) | Pharmaceutical preparations that include anthraxtinib | |
| PT3202759T (pt) | Derivado de alfa-aminoamida e composição farmacêutica contendo o mesmo | |
| PL3253231T3 (pl) | Kompozycje przeciwdrobnoustrojowe zawierające ekstrakty z Punica i Lamiaceae | |
| CA3297520A1 (en) | Synergistic glycocalyx treatment compositions and methods | |
| PL3258948T3 (pl) | Kompozycje przeciwzapalne i immunomodulujące zawierające klebsormidium i ich zastosowania | |
| IL248773B (en) | History -6,1-Naphthyridine-5,4-Dione and pharmaceutical preparations containing them | |
| GB201502002D0 (en) | Uses and compositions | |
| IL266840A (en) | History of tyrosine and preparations containing them | |
| EP3223632A4 (en) | Novel diterpene glycosides, compositions and purification methods | |
| SG10202106375UA (en) | Pharmaceutical compositions and use thereof | |
| GB201501991D0 (en) | Uses and compositions | |
| GB201502026D0 (en) | Uses and compositions | |
| IL254711B (en) | History of diazepine-indole and medicinal preparations containing them | |
| PL3544615T3 (pl) | Kompozycja doustna zawierająca beta-escynę i sok z aronii do obniżania toksyczności aldehydu octowego | |
| PL3568203T3 (pl) | Związki i kompozycje | |
| EP3223608A4 (en) | Novel diterpene glycosides, compositions and purification methods |